Kayne Anderson Rudnick Investment Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3M | Buy |
29,025
+1,030
| +4% | +$91.9K | 0.01% | 309 |
|
|
2026
Q1 | $2.01M | Sell |
27,995
-8,821
| -24% | -$680K | 0.01% | 327 |
|
|
2025
Q4 | $2.92M | Sell |
36,816
-625
| -2% | -$49.3K | 0.01% | 304 |
|
|
2025
Q3 | $2.82M | Sell |
37,441
-180
| -0.5% | -$12.3K | 0.01% | 302 |
|
|
2025
Q2 | $2.6M | Sell |
37,621
-5,817
| -13% | -$381K | 0.01% | 312 |
|
|
2025
Q1 | $2.94M | Buy |
43,438
+12,661
| +41% | +$758K | 0.01% | 307 |
|
|
2024
Q4 | $1.38M | Sell |
30,777
-4,534
| -13% | -$254K | ﹤0.01% | 369 |
|
|
2024
Q3 | $2.22M | Buy |
35,311
+14,702
| +71% | +$858K | ﹤0.01% | 333 |
|
|
2024
Q2 | $1.22M | Sell |
20,609
-60,481
| -75% | -$3.78M | ﹤0.01% | 379 |
|
|
2024
Q1 | $6.47M | Sell |
81,090
-3,195
| -4% | -$244K | 0.02% | 273 |
|
|
2023
Q4 | $6.66M | Sell |
84,285
-5,684
| -6% | -$405K | 0.02% | 274 |
|
|
2023
Q3 | $6.28M | Sell |
89,969
-1,382
| -2% | -$97.9K | 0.02% | 276 |
|
|
2023
Q2 | $6.32M | Sell |
91,351
-3,341
| -4% | -$238K | 0.02% | 277 |
|
|
2023
Q1 | $7.04M | Buy |
94,692
+6,924
| +8% | +$581K | 0.02% | 270 |
|
|
2022
Q4 | $8.18M | Sell |
87,768
-2,529
| -3% | -$244K | 0.03% | 268 |
|
|
2022
Q3 | $8.61M | Buy |
90,297
+3,552
| +4% | +$352K | 0.03% | 254 |
|
|
2022
Q2 | $8.04M | Buy |
86,745
+891
| +1% | +$87K | 0.03% | 256 |
|
|
2022
Q1 | $8.69M | Buy |
85,854
+2,830
| +3% | +$297K | 0.02% | 250 |
|
|
2021
Q4 | $8.56M | Buy |
83,024
+1,450
| +2% | +$134K | 0.02% | 251 |
|
|
2021
Q3 | $6.92M | Buy |
81,574
+2,905
| +4% | +$243K | 0.02% | 253 |
|
|
2021
Q2 | $6.56M | Buy |
78,669
+3,950
| +5% | +$323K | 0.02% | 251 |
|
|
2021
Q1 | $5.62M | Buy |
74,719
+9,099
| +14% | +$663K | 0.02% | 252 |
|
|
2020
Q4 | $4.48M | Buy |
65,620
+576
| +0.9% | +$37.5K | 0.01% | 263 |
|
|
2020
Q3 | $3.8M | Sell |
65,044
-2,439
| -4% | -$152K | 0.01% | 255 |
|
|
2020
Q2 | $4.38M | Sell |
67,483
-16,777
| -20% | -$1.06M | 0.02% | 228 |
|
|
2020
Q1 | $5M | Sell |
84,260
-22,897
| -21% | -$1.53M | 0.03% | 211 |
|
|
2019
Q4 | $7.96M | Sell |
107,157
-7,284
| -6% | -$511K | 0.04% | 194 |
|
|
2019
Q3 | $7.22M | Buy |
114,441
+36,421
| +47% | +$2.16M | 0.04% | 196 |
|
|
2019
Q2 | $4.25M | Sell |
78,020
-399
| -0.5% | -$21.5K | 0.02% | 232 |
|
|
2019
Q1 | $4.23M | Buy |
78,419
+3,469
| +5% | +$214K | 0.02% | 215 |
|
|
2018
Q4 | $4.91M | Sell |
74,950
-7,628
| -9% | -$569K | 0.03% | 204 |
|
|
2018
Q3 | $6.5M | Sell |
82,578
-7,357
| -8% | -$526K | 0.04% | 192 |
|
|
2018
Q2 | $5.79M | Buy |
89,935
+4,198
| +5% | +$277K | 0.04% | 196 |
|
|
2018
Q1 | $5.33M | Buy |
85,737
+30,283
| +55% | +$2.17M | 0.04% | 191 |
|
|
2017
Q4 | $4.02M | Sell |
55,454
-10,049
| -15% | -$731K | 0.03% | 210 |
|
|
2017
Q3 | $5.33M | Buy |
65,503
+1,673
| +3% | +$132K | 0.05% | 193 |
|
|
2017
Q2 | $5.14M | Buy |
63,830
+3,757
| +6% | +$297K | 0.05% | 196 |
|
|
2017
Q1 | $4.72M | Buy |
60,073
+20,874
| +53% | +$1.67M | 0.05% | 199 |
|
|
2016
Q4 | $3.09M | Buy |
39,199
+35
| +0.1% | +$2.83K | 0.04% | 216 |
|
|
2016
Q3 | $3.48M | Buy |
39,164
+3,106
| +9% | +$293K | 0.04% | 205 |
|
|
2016
Q2 | $3.45M | Buy |
36,058
+3,083
| +9% | +$307K | 0.05% | 193 |
|
|
2016
Q1 | $3.42M | Buy |
32,975
+9,317
| +39% | +$906K | 0.06% | 181 |
|
|
2015
Q4 | $2.31M | Buy |
23,658
+14,246
| +151% | +$1.4M | 0.04% | 213 |
|
|
2015
Q3 | $908K | Buy |
+9,412
| New | +$989K | 0.02% | 265 |
|
Other funds holding CVS
Kayne Anderson Rudnick Investment Management's CVS Position: Q2 2026 in Review
Kayne Anderson Rudnick Investment Management increased its CVS Health (CVS) stake by 3.7% in Q2 2026, buying an estimated $91.9K and bringing the position to 29,025 shares worth $3M. The position accounts for 0.01% of the portfolio, ranked #309.
Kayne Anderson Rudnick Investment Management first reported a position in CVS in Q3 2015 and has held it in 44 quarters since. The position peaked at $8.69M in Q1 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Kayne Anderson Rudnick Investment Management held 29,025 shares of CVS Health worth $3M as of Q2 2026.
- Kayne Anderson Rudnick Investment Management bought 1,030 CVS Health shares in Q2 2026, an estimated $91.9K.
- CVS Health made up 0.01% of Kayne Anderson Rudnick Investment Management's portfolio in Q2 2026, its #309 holding.
- Kayne Anderson Rudnick Investment Management first reported a position in CVS Health in Q3 2015 and has held it in 44 quarters since.
- Kayne Anderson Rudnick Investment Management's CVS Health position peaked at $8.69M in Q1 2022.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.